These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. Sayasone S, Keiser J, Meister I, Vonghachack Y, Xayavong S, Senggnam K, Phongluxa K, Hattendorf J, Odermatt P. Lancet Infect Dis; 2018 Feb; 18(2):155-161. PubMed ID: 29153938 [Abstract] [Full Text] [Related]
9. Artemether, artesunate, praziquantel and tribendimidine administered singly at different dosages against Clonorchis sinensis: a comparative in vivo study. Xiao SH, Jian X, Tanner M, Yong-Nian Z, Keiser J, Utzinger J, Hui-Qiang Q. Acta Trop; 2008 Apr; 106(1):54-9. PubMed ID: 18308285 [Abstract] [Full Text] [Related]
12. Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis. Qian MB, Patel C, Palmeirim MS, Wang X, Schindler C, Utzinger J, Zhou XN, Keiser J. Lancet Microbe; 2022 Aug; 3(8):e616-e624. PubMed ID: 35697047 [Abstract] [Full Text] [Related]
13. [Experimental study progress on tribendimidine, artemether and artesunate against Clonorchis sinensis and other trematodes]. Xiao SH, Xue J, Wu ZX. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Feb 28; 27(1):65-9. PubMed ID: 19459505 [Abstract] [Full Text] [Related]
17. Effect of single-dose oral artemether and tribendimidine on the tegument of adult Clonorchis sinensis in rats. Xiao SH, Keiser J, Xue J, Tanner M, Morson G, Utzinger J. Parasitol Res; 2009 Feb 28; 104(3):533-41. PubMed ID: 18975004 [Abstract] [Full Text] [Related]
18. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini. Keiser J, Shu-Hua X, Chollet J, Tanner M, Utzinger J. Antimicrob Agents Chemother; 2007 Mar 28; 51(3):1096-8. PubMed ID: 17194822 [Abstract] [Full Text] [Related]
19. Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials. Sayasone S, Odermatt P, Vonghachack Y, Xayavong S, Senggnam K, Duthaler U, Akkhavong K, Hattendorf J, Keiser J. Lancet Infect Dis; 2016 Oct 28; 16(10):1145-1153. PubMed ID: 27472949 [Abstract] [Full Text] [Related]